2022 update on prostate cancer epidemiology and risk factors—a systematic review

O Bergengren, KR Pekala, K Matsoukas, J Fainberg… - European urology, 2023 - Elsevier
Abstract Context Prostate cancer (PCa) is one of the most common cancers worldwide.
Understanding the epidemiology and risk factors of the disease is paramount to improve …

PI-RADS: where next?

B Turkbey, AS Purysko - Radiology, 2023 - pubs.rsna.org
Prostate MRI plays an important role in the clinical management of localized prostate
cancer, mainly assisting in biopsy decisions and guiding biopsy procedures. The Prostate …

Evaluating the feasibility of ChatGPT in healthcare: an analysis of multiple clinical and research scenarios

M Cascella, J Montomoli, V Bellini… - Journal of medical systems, 2023 - Springer
This paper aims to highlight the potential applications and limits of a large language model
(LLM) in healthcare. ChatGPT is a recently developed LLM that was trained on a massive …

Early detection of prostate cancer: AUA/SUO guideline part II: considerations for a prostate biopsy

JT Wei, D Barocas, S Carlsson, F Coakley… - Journal of …, 2023 - journals.lww.com
Purpose: The summary presented herein covers recommendations on the early detection of
prostate cancer and provides a framework to facilitate clinical decision-making in the …

Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit

A Vickers, F O'Brien, F Montorsi, D Galvin, O Bratt… - bmj, 2023 - bmj.com
Current policies on early detection of prostate cancer create overdiagnosis and inequity with
minimal benefit Page 1 Current policies on early detection of prostate cancer create …

[HTML][HTML] Population-based organised prostate cancer testing: results from the first invitation of 50-year-old Men

O Bratt, RA Godtman, T Jiborn, J Wallström, O Akre… - European Urology, 2024 - Elsevier
Abstract Background The European Union recently recommended evaluation of the
feasibility of organised prostate cancer screening. In Sweden, regional population-based …

Multiparametric magnetic resonance imaging in prostate cancer screening at the age of 45 years: results from the first screening round of the PROBASE trial

M Boschheidgen, P Albers, HP Schlemmer, S Hellms… - European urology, 2024 - Elsevier
Background Magnetic resonance imaging (MRI) has been suggested as a tool for guiding
biopsy recommendations in prostate cancer (PC) screening. Objective To determine the …

Targeted biopsy in men high risk for prostate cancer: 68Ga-PSMA PET/CT versus mpMRI

P Pepe, M Pennisi - Clinical Genitourinary Cancer, 2023 - Elsevier
Abstract Introduction/Background To evaluate the accuracy of 68Ga-PSMA PET/CT versus
mpMRI targeted biopsy (TPBx) in the diagnosis of clinically significant prostate cancer …

Reducing prostate cancer Overdiagnosis

R Gulati - New England Journal of Medicine, 2022 - Mass Medical Soc
Prostate cancer is a major public health problem, having caused more than 375,000 deaths
worldwide in 2020.1 One of the main tools available to lessen this burden is prostate …

Deep learning super-resolution reconstruction for fast and motion-robust T2-weighted prostate MRI

LM Bischoff, JM Peeters, L Weinhold, P Krausewitz… - Radiology, 2023 - pubs.rsna.org
Background Deep learning (DL) reconstructions can enhance image quality while
decreasing MRI acquisition time. However, DL reconstruction methods combined with …